

Please try another search
Cathie Wood announced the upcoming closure of the ARK Transparency ETF Despite declines, investors continue to follow Wood’s holdings closely Consider 2 Ark Invest ETFs that offer better value...
USANA Health (NYSE:USNA) Sciences Inc. USNA is scheduled to report second-quarter 2020 results on Jul 21, aftermarketclose. The company flaunts a mixedearningssurprise history, having surpassed...
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) announced that the European Commission has approved Givlaari (givosiran) for the treatment of acute hepatic porphyria (AHP) in patients aged 12 years or...
Pfizer, Inc. (NYSE:PFE) announced that the European Commission has granted approval to C(tafamidis) capsule to treat wild-type or hereditary transthyretin amyloidosis in adult patients with...
ProQR Therapeutics N.V. (NASDAQ:PRQR) announced that it has dosed the first patient in a phase I/II study, Aurora, evaluating its investigational RNA-based candidate QR-1123 for the treatment of...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is...
It was a low-key week for the biotech sector with very few updates. Bigwig Gilead Sciences (NASDAQ:GILD) obtained FDA approval for the label expansion of Descovy, while Akcea Therapeutics, Inc....
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that the FDA has granted Breakthrough Therapy designation to its oral factor D inhibitor, danicopan (previously ACH-4471), as a treatment for...
Biogen Inc. (NASDAQ:BIIB) announced that it has initiated a phase II/III study on its spinal muscular atrophy (SMA) drug Spinraza (nusinersen). The DEVOTE study will evaluate a higher dose of...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) announced that it has out-licensed its antisense medicine candidates for treating patients with chronic hepatitis B (CHB) virus infection to pharma giant...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review